Impact of the Chronic Care Model on medication adherence when patients perceive cost as a barrier

被引:26
|
作者
Mackey, Katherine [2 ]
Parchman, Michael L. [2 ,3 ]
Leykum, Luci K. [3 ,4 ]
Lanham, Holly J. [3 ,4 ]
Noel, Polly H. [3 ,4 ]
Zeber, John E. [1 ,5 ]
机构
[1] Scott & White Healthcare, Ctr Appl Hlth Res, Temple, TX 76502 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA
[3] S Texas Vet Hlth Care Syst VERDICT HSR&D, Dept Vet Affairs, San Antonio, TX USA
[4] Univ Texas Hlth Sci Ctr San Antonio, Dept Internal Med, San Antonio, TX 78229 USA
[5] Cent Texas Vet Hlth Care Syst, Temple, TX USA
关键词
Diabetes; Medication adherence; Chronic care delivery; Out-of-pocket cost; CHRONIC ILLNESS CARE; CONCEPTUALLY BASED APPROACH; SELF-MANAGEMENT; BIPOLAR DISORDER; RANDOMIZED-TRIAL; NONADHERENCE; PRESCRIPTIONS; VALIDATION; PRESSURES; OUTCOMES;
D O I
10.1016/j.pcd.2011.12.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Cost burdens represent a significant barrier to medication adherence among chronically ill patients, yet financial pressures may be mitigated by clinical or organizational factors, such as treatment aligned with the Chronic Care Model (CCM). This study examines how perceptions of chronic illness care attenuate the relationship between adherence and cost burden. Methods: Surveys were administered to patients at 40 small community-based primary care practices. Medication adherence was assessed using the 4-item Morisky scale, while five cost-related items documented recent pharmacy restrictions. CCM experiences were assessed via the 20-item Patient Assessment of Chronic Illness Care (PACIC). Nested random effects models determined if chronic care perceptions modified the association between medication adherence and cost-related burden. Results: Of 1823 respondents reporting diabetes and other chronic diseases, one-quarter endorsed intrapersonal adherence barriers, while 23% restricted medication due of cost. Controlling for age and health status, the relationship between medication cost and CCM with adherence was significant; including PACIC scores attenuated cost-related problems patients with adequate or problematic adherence behavior. Conclusions: Patients experiencing treatment more consistent with the CCM reported better adherence and lower cost-related burden. Fostering highly activated patients and shared clinical decision making may help alleviate medication cost pressures and improve adherence. Published by Elsevier Ltd on behalf of Primary Care Diabetes Europe.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 50 条
  • [41] Implementation of a medication adherence intervention for chronic leukemia patients
    Muluneh, Benyam
    Macker, Emily
    Bryant, Ashley Leak
    Wood, William
    Wheeler, Stephanie
    Lafata, Jennifer Elston
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (01) : 298 - 299
  • [42] A comparison of barriers to medication adherence in patients with chronic conditions
    Hahn, S.
    Yu-Isenberg, K.
    Priest, J.
    Skinner, E.
    Weaver, M.
    Olson, P.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 : 1 - 2
  • [43] PATIENTS MEDICATION ADHERENCE IN CHRONIC DISEASES IN ZAGREB (CROATIA)
    Culig, J.
    Boskovic, J.
    Huml, D.
    Leppee, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 94 - 94
  • [44] THE IMPACT OF A PHARMACY OPERATIONS MODEL ON IMPROVING MEDICATION ADHERENCE
    Pickering, M.
    Nelson, M.
    VALUE IN HEALTH, 2017, 20 (05) : A36 - A36
  • [45] Impact of a clinical pharmacist-led, artificial intelligence-supported medication adherence program on medication adherence performance, chronic disease control measures, and cost savings
    Worrall, Charles
    Shirley, David
    Bullard, Jeff
    Dao, Ashley
    Morrisette, Taylor
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2025, 65 (01)
  • [46] Impact of Primary Care Intensive Management on Medication Adherence and Adjustments
    Yoon, Jean
    Wu, Frances
    Chang, Evelyn
    AMERICAN JOURNAL OF MANAGED CARE, 2020, 26 (08): : E239 - +
  • [47] THE IMPACT OF MEDICATION ADHERENCE ON THE COST OF OSTEOPOROSIS FRACTURES IN GERMANY: A MODELLING APPROACH
    Stephens, J. M.
    Brotherton, S. A.
    Gitlin, M. D.
    Steinle, T.
    Leidl, R.
    Kochevar, J. J.
    VALUE IN HEALTH, 2010, 13 (07) : A310 - A310
  • [48] COST OF MEDICATION NON-ADHERENCE AMONG PATIENTS ON IMMUNOSUPPRESSANTS
    Refeld, R. R.
    Witt, E.
    VALUE IN HEALTH, 2022, 25 (07) : S410 - S410
  • [49] When do physicians perceive the success of a new care model differently?
    Simone Richter
    Ibrahim Demirer
    Maya Nocon
    Holger Pfaff
    Ute Karbach
    BMC Health Services Research, 21
  • [50] When do physicians perceive the success of a new care model differently?
    Richter, Simone
    Demirer, Ibrahim
    Nocon, Maya
    Pfaff, Holger
    Karbach, Ute
    BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)